In this study, responses of oral squamous cell carcinomas (OSCCs) to catalytic inhibition of JARID1B were assessed using CPI-455, the first tool compound with true JARID1 family selectivity. The gene discussed is KDM5B; the disease is oral cavity squamous cell carcinoma.